Marie-ange Demoitie

Rixensart, WAL 1330, Belgium

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Immunogenicity and safety of an investigational quadrivalent measles, mumps, rubella, and varicella vaccine in children aged 4-6 years: A phase II, randomized, multi-country trial.

Immunogenicity and safety of an investigational quadrivalent measles, mumps, rubella, and varicella vaccine in children aged 4-6 years: A phase II, randomized, multi-country trial.

Journal: Human vaccines & immunotherapeutics
Published: May 26, 2026

Genetic characterization of M. tuberculosis isolates from participants in a Phase 2b randomized trial evaluating the M72/AS01E tuberculosis candidate vaccine.

Genetic characterization of M. tuberculosis isolates from participants in a Phase 2b randomized trial evaluating the M72/AS01E tuberculosis candidate vaccine.

Journal: The Journal of infectious diseases
Published: April 30, 2026

Non-clinical evaluation of local and systemic immunity induced by different vaccination strategies of the candidate tuberculosis vaccine M72/AS01.

Non-clinical evaluation of local and systemic immunity induced by different vaccination strategies of the candidate tuberculosis vaccine M72/AS01.

Journal: Tuberculosis (Edinburgh, Scotland)
Published: July 04, 2023

Subsequent AS01-adjuvanted vaccinations induce similar transcriptional responses in populations with different disease statuses.

Subsequent AS01-adjuvanted vaccinations induce similar transcriptional responses in populations with different disease statuses.

Journal: PloS one
Published: March 25, 2022

Final Analysis of a Trial of M72/AS01E Vaccine to Prevent Tuberculosis.

Final Analysis of a Trial of M72/AS01E Vaccine to Prevent Tuberculosis.

Journal: The New England journal of medicine
Published: October 30, 2019

Long-term safety and immunogenicity of the M72/AS01E candidate tuberculosis vaccine in HIV-positive and -negative Indian adults: Results from a phase II randomized controlled trial.

Long-term safety and immunogenicity of the M72/AS01E candidate tuberculosis vaccine in HIV-positive and -negative Indian adults: Results from a phase II randomized controlled trial.

Journal: Medicine
Published: November 09, 2018

Phase 2b Controlled Trial of M72/AS01E Vaccine to Prevent Tuberculosis.

Phase 2b Controlled Trial of M72/AS01E Vaccine to Prevent Tuberculosis.

Journal: The New England journal of medicine
Published: October 04, 2018

Safety and immunogenicity of the M72/AS01E candidate tuberculosis vaccine in adults with tuberculosis: A phase II randomised study.

Safety and immunogenicity of the M72/AS01E candidate tuberculosis vaccine in adults with tuberculosis: A phase II randomised study.

Journal: Tuberculosis (Edinburgh, Scotland)
Published: April 07, 2016

A Randomized, Controlled Safety, and Immunogenicity Trial of the M72/AS01 Candidate Tuberculosis Vaccine in HIV-Positive Indian Adults.

A Randomized, Controlled Safety, and Immunogenicity Trial of the M72/AS01 Candidate Tuberculosis Vaccine in HIV-Positive Indian Adults.

Journal: Medicine
Published: January 29, 2016

Safety and immunogenicity of candidate vaccine M72/AS01E in adolescents in a TB endemic setting.

Safety and immunogenicity of candidate vaccine M72/AS01E in adolescents in a TB endemic setting.

Journal: Vaccine
Published: March 12, 2015

Safety and immunogenicity of the M72/AS01 candidate tuberculosis vaccine in HIV-infected adults on combination antiretroviral therapy: a phase I/II, randomized trial.

Safety and immunogenicity of the M72/AS01 candidate tuberculosis vaccine in HIV-infected adults on combination antiretroviral therapy: a phase I/II, randomized trial.

Journal: AIDS (London, England)
Published: June 10, 2014

Safety and immunogenicity of the M72/AS01 candidate tuberculosis vaccine when given as a booster to BCG in Gambian infants: an open-label randomized controlled trial.

Safety and immunogenicity of the M72/AS01 candidate tuberculosis vaccine when given as a booster to BCG in Gambian infants: an open-label randomized controlled trial.

Journal: Tuberculosis (Edinburgh, Scotland)
Published: March 26, 2014
Showing 1-12 of 18

Last Updated: 09/26/2026